Oropharyngeal Candidiasis (OPC) and S-ECC
NCT05761197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-07-14
Summary
The overall objective of this study is to investigate the association of early Candida infection (known as oral thrush or oropharyngeal candidiasis, OPC) in children during the first year of life with the onset and severity of severe early childhood caries (S-ECC).
Conditions
- Candida Infection
- Oral Thrush
- Early Childhood Caries
Sponsors & Collaborators
-
Children's Hospital of Philadelphia
collaborator OTHER -
Temple University
lead OTHER
Principal Investigators
-
Yuan Liu, DDS, MS, PhD · Temple University Kornberg School of Dentistry
Eligibility
- Min Age
- 9 Months
- Max Age
- 24 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2028-08-31
- Completion
- 2028-08-31
Countries
- United States
Study Locations
More Related Trials
-
The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive Candidiasis
NCT00056368 ·Status: COMPLETED ·Phase: PHASE3
-
Study of FK463 in the Treatment of Candidemia or Invasive Candidiasis
NCT00036179 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT03561701 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics (PK) Study of a Fluconazole Loading Dose in Infants and Toddlers
NCT00797420 ·Status: COMPLETED ·Phase: PHASE1
-
Vulvovaginal Candidiasis in Canadian Females
NCT04930107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Pharmacokinetics of Micafungin in Children on Extracorporeal Membrane Oxygenation
NCT01666769 ·Status: COMPLETED ·Phase: PHASE1
-
Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
NCT03253094 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Candida in Infants and Dietary Type
NCT01438983 ·Status: COMPLETED
-
A Study of Oral Oteseconazole for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT03562156 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis
NCT02679456 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)
NCT04029116 ·Status: COMPLETED ·Phase: PHASE3
-
PEACE: Pediatric Antifungal Comparative Effectiveness
NCT01869829 ·Status: COMPLETED
-
Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis
NCT00815516 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy of Caspofungin Versus Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants (MK-0991-064)
NCT01945281 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
NCT03987620 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic Study of Fluconazole in Premature Infants
NCT01683760 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility
NCT00692783 ·Status: TERMINATED
-
Oral Ibrexafungerp (SCY-078) vs Standard-of-Care Following IV Echinocandin in the Treatment of Invasive Candidiasis
NCT02244606 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children
NCT00174473 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients
NCT00002446 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric Patients
NCT01092832 ·Status: TERMINATED ·Phase: PHASE3
-
Pharmacokinetics of Fluconazole in Children (2-18 Years)
NCT05130723 ·Status: UNKNOWN
-
Efficacy of Prophylactic Fluconazole Therapy in Preterm and Very Low Birth Weight Neonates in Preventing Invasive Fungal Infection.
NCT05848492 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097)
NCT02452034 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Oral Oteseconazole (VT-1161) for Acute Yeast Infections in Patients With Recurrent Yeast Infections
NCT03840616 ·Status: COMPLETED ·Phase: PHASE3